Pay-for-delay deals are disliked by regulators on both sides of the Atlantic. A month after the U.S. Supreme Court heard arguments on the practices, regulators in the U.K. have turned to a decade-old deal, no longer place, to accuse GlaxoSmithKline of paying competitors to keep generics off the market.
Now that Obamacare has had its day at the Supreme Court, pharma has another case to worry about. The longstanding debate over "pay-for-delay" deals with generics companies could soon make its way to the high court, legal experts say. And if it does, branded drugmakers and generics companies would face a wholesale shift in their business strategies.
A federal appeals court pulled a pay-to-delay challenge out of mothballs, forcing Merck to fight claims that its Schering-Plough unit delayed generic versions of its potassium drug K-Dur. But Merck isn't the only drugmaker that should keep an eye on this case.
Here's one way to curb pay-for-delay patent settlements: Broaden the field of successful patent challengers. A bill set for introduction in the U.S. Senate would amend the Hatch-Waxman Act, which
The debate over pay-to-delay deals played out in microcosm at an American Bar Association panel yesterday. As Legal Times reports, the Federal Trade Commission's deputy assistant director Bradley
The Congressional Budget Office has analyzed the proposed pay-to-delay ban, and its money-saving estimate comes in at almost $5 billion. According to CBO, the Preserve Access to Affordable Generic
It's no coincidence that the Federal Trade Commission released new "pay for delay" numbers yesterday, just as the Congressional budget-cutting committee nears its deadline. The FTC wanted to
President Obama's deficit-cutting plan hits pharma with a one-two-three punch. As he's advocated before, Obama would impose higher drug rebates on dual-eligibles, the low-income Medicare patients who
The Federal Trade Commission is considering using its rule-making power to stop so-called pay-for-delay deals between branded drugmakers and generics companies after failing to get judges or Congress